Forum Alert: BioSante Pharmaceuticals, Inc. will Present at the Informed Investors Biotechnology & Healthcare Investor Forum at The Hyatt Regency in San Francisco on Wednesday, December 7, 2005, 10:50 am PST.
What: Informed Investors Biotechnology & Healthcare Investor Forum in San Francisco
When: December 7, 2005 @ 10:50 AM Pacific Standard Time
Sponsors: Barron's, The Wall Street Journal and Business Wire
Keynote Presentations: John McCamant, Editor of The Medical Technology Stock Letter, Adam Noah, Ph.D., Vice President, Biotechnology Equity Research, Merriman Curhan Ford & Co.
Forum Highlights Include: Networking session and Industry Panel Discussion at the conclusion of the presentations
Where: The Hyatt Regency Hotel, 5 Embarcadero Center, San Francisco, CA 94111
How to attend: Pre-registration is necessary. To register, contact Cary Loeser, firstname.lastname@example.org, or 804-327-3407. You may also call Customer Service at 888-301-6618, or register at the following link: http://www.investorcalendar.com/IIF/CustomEvent/90563/index.asp
If you are unable to attend the live event, the forum will be archived and available via webcast at http://www.investorcalendar.com/IIF/CustomEvent/90563/index.asp
Contact: Phillip Donenberg, Chief Financial Officer, email@example.com , (847)478-0500
BioSante is developing a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone. BioSante's lead products include Bio-E-Gel(TM) (bioidentical estradiol gel) for the treatment of women with menopausal symptoms, and LibiGel(TM) (bioidentical testosterone gel) for the treatment of female sexual dysfunction (FSD). The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion. The company also is developing its calcium phosphate nanotechnology (CAP) for novel vaccines, including biodefense vaccines for toxins such as anthrax and ricin, and drug delivery systems.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 30, 2005|
|Previous Article:||Toshiba Expands Cardiac CT Training Program for Aquilion 64 Customers; Expansion Aimed at Meeting Industry Demand for Practical Training Using...|
|Next Article:||A Record of the Topics Discussed at the 8th Real Estate & Investment Forum Which Was Attended by over 500 Key Real Estate Players.|